Companies / Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

Nasdaq: DNTHCIK 1690585NEW YORK, NYmagentatx.com

Financials · FY2025

Revenue$2.04M
Net income$-162.34M
Total debt
Cash$110.55M
Diluted EPS$-4.20
Shares outstanding55.9M

Ownership

55.9M shares outstanding · as of Aug 3, 2026
0.12%Insiders
Ownership
Insiders0.12%65,292
10%+ / strategic11.86%6,632,303
Institutions97.74%54,668,022
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Garcia MarinoCEOCEO AND PRESIDENT · Director
0.12%65,292
Carr EdwardCHIEF ACCOUNTING OFFICER
0.00%0
Randhawa SimratEVP, Head of R&D
0.00%0
0.00%0
Kango SujayDirector
Savitz RyanEVP, CFO & CBO
Veness Adam MSVP, General Counsel and Sec.

Institutional holders 189

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
Add$215.29M+2.2M
+115.32%
4,123,822
7.37% of shares
high
Q1 2026
as of
Deerfield Management Company, L.P.
13F manager
New$85.58M+1.0M
1,019,813
1.82% of shares
high
Q1 2026
as of
RA Capital Management, L.P.
13F manager
Add$83.92M+1.0M
+62.05%
2,611,733
4.67% of shares
high
Q2 2026
as of
State Street Corporation
13F manager
Add$82.84M+850K
+56.37%
2,357,440
4.21% of shares
high
Q1 2026
as of
Marshall Wace, LLP
13F manager
Trim$-55.94M-667K
-66.10%
341,929
0.61% of shares
high
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
New$39.79M+474K
474,085
0.85% of shares
medium
Q1 2026
as of
Millennium Management LLC
13F manager
Trim$-34.01M-405K
-60.74%
261,962
0.47% of shares
medium
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
Trim$-20.14M-240K
-50.45%
235,748
0.42% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
T. Rowe Price Investment Management, Inc.Passive13G/A6,632,303
T. Rowe Price Investment Management, Inc.Passive13G3,888,456
RA Capital Management, L.P.Passive13G/A
Point72 Asset Management, L.P.Passive13G/A
RA Capital Management, L.P.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DNTH252828108